Faculty, Staff and Student Publications
Publication Date
4-1-2023
Journal
JAC-Antimicrobial Resistance
Abstract
BACKGROUND: Fluoroquinolones are used for infection prevention in high-risk patients with haematological malignancies. Fluoroquinolones are active against many Gram-negative bacilli (GNB) but are less active against Gram-positive organisms. We evaluated the
METHODS: Antimicrobial susceptibility testing and time-kill studies were performed using CLSI-approved methodology and interpretive criteria for 350 Gram-positive organisms and 210 GNB that had been recently isolated from patients with cancer.
RESULTS: Delafloxacin was more active than ciprofloxacin and levofloxacin against
CONCLUSIONS: Delafloxacin is more active than ciprofloxacin and levofloxacin against
DOI
10.1093/jacamr/dlad034
PMID
36994231
PMCID
PMC10041357
PubMedCentral® Posted Date
March 2023
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Medical Pathology Commons, Medical Toxicology Commons, Oncology Commons, Pathological Conditions, Signs and Symptoms Commons, Pathology Commons
Comments
PMID: 36994231